7 days of meditation rewires brain, mimics psychedelics
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- UC San Diego researchers published in Communications Biology that a 7-day residential meditation retreat produced measurable changes in brain networks, blood chemistry, and immune signaling across 20 healthy adults.
- Brain scans showed reduced activity in regions linked to internal mental chatter, while post-retreat blood plasma encouraged lab-grown neurons to extend and form new connections and increased glycolytic metabolism.
- Endogenous opioids — the body's natural painkillers — rose after the retreat, alongside increases in both inflammatory and anti-inflammatory immune signals indicating a balanced, adaptive immune response.
- Mystical experience scores on the MEQ-30 questionnaire rose from an average of 2.37 before the retreat to 3.02 afterward, and participants reporting stronger mystical experiences also showed greater coordination between brain regions.
- Senior author Hemal H. Patel said the post-retreat brain activity patterns "closely resembled" those typically associated with psilocybin — achieved through meditation practice alone, without any drugs.
- Co-author Joe Dispenza, who led the retreat, is employed by Encephalon, Inc., the company offering the program — a disclosed conflict of interest that the psychedelic-comparison headlines largely ignore.
Why it matters: A 7-day meditation retreat producing measurable whole-body changes in 20 healthy adults is biologically provocative, but the dominant psychedelic-comparison angle buries the fact that lead retreat instructor Joe Dispenza co-authored the study on his own company's program. Future trials in chronic pain, mood disorders, and immune conditions — the applications researchers explicitly plan to explore — will determine whether these effects hold up under controlled conditions.
Ask SkimNews
